Tryptanthrin-loaded nanoparticles for delivery into cultured human breast cancer cells, MCF7: The effects of solid lipid/liquid lipid ratios in the inner core

Chemical and Pharmaceutical Bulletin

Volumn 59, Issue 2, 2011, Pages 266-271

  Fang, Yi Ping ^a   Lin, Yin Ku ^b,c   Su, Yu Han ^d   Fang, Jia You ^d,e  

^a YUANPEI UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Delivery; Human breast cancer cell; Multidrug resistance; Nanostructured lipid carrier; Solid lipid nanoparticle; Tryptanthrin

Indexed keywords

DRUG CARRIER; GLYCEROL BEHENATE; LIPID EMULSION; NANOPARTICLE; NANOSTRUCTURED LIPID CARRIER; SOLID LIPID NANOPARTICLE; SQUALENE; TRYPTANTHRIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL MEDIATED CYTOTOXICITY; CELL STRAIN MCF 7; CONFOCAL LASER MICROSCOPY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; EMULSION; ENDOCYTOSIS; HUMAN; HUMAN CELL; NANOENCAPSULATION; PARTICLE SIZE; PARTITION COEFFICIENT; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

BREAST NEOPLASMS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; LIPIDS; NANOPARTICLES; QUINAZOLINES; SOLUBILITY; TUMOR CELLS, CULTURED;

EID: 79551501142     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.59.266     Document Type: Article

References (25)

1. Gottesman M. M., Fojo T., Bates S. E., Nat. Rev. Cancer, 2, 48-58 (2002).
2. Scotto K. W., Oncogene, 22, 7496-7511 (2003).
3. Gottesman M.M., Ling V., FEBS Lett., 580, 998-1009 (2006).
4. Yu S. T., Chen T. M., Tseng S. Y., Chen Y. H., Biochem. Biophys. Res. Commun., 358, 79-84 (2007).
5. Jao C. W., Lin W. C., Wu Y. T., Wu P. L., J. Nat. Prod., 71, 1275-1279 (2008).
6. Danz H., Stoyanova S., Wippich P., Brattström A., Hamburger M., Planta Med., 67, 411-416 (2001).
7. Sharma V. M., Prasanna P., Seshu K. V., Renuka B., Rao C. V., Kumar G. S., Narasimhulu C. P., Babu P. A., Puranik R. C., Subramanyam D., Venkateswarlu A., Rajagopal S., Kumar K. B., Rao C. S., Mamidi N. V., Deevi D. S., Ajaykumar R., Rajagopalan R., Bioorg. Med. Chem. Lett., 12, 2303-2307 (2002).
8. Koya-Miyata S., Kimoto T., Micallef M. J., Hino K., Taniguchi M., Ushio S., Iwaki K., Ikeda M., Kurimoto M., Anticancer Res., 21, 3295-3300 (2001).
9. Ogretmen B., Safa A. R., Biochemistry, 38, 2189-2199 (1999).
10. Chen G. S., Bhagwat B. V., Liao P. Y., Chen H. T., Lin S. B., Chern J. W., Bioorg. Med. Chem. Lett., 17, 1769-1772 (2007).
11. Jin S., Ye K., Biotechnol. Prog., 23, 32-41 (2007).
12. Müller R. H., Radtke M., Wissing S. A., Adv. Drug Deliv. Rev., 54, S131-S155 (2002).
13. Driscoll D. F., Pharm. Res., 23, 1959-1969 (2006).
14. Müller R. H., Radtke M., Wissing S. A., Int. J. Pharm., 242, 121-128 (2002).
15. Jores K., Haberland A., Wartewig S., Mäder K., Mehnert W., Pharm. Res., 22, 1887-1897 (2005).
16. Hu F. Q., Jiang S. P., Du Y. Z., Yuan H., Ye Y. Q., Zeng, S., Colloids Surface B, 45, 167-173 (2005).
17. Buszello K., Harnisch S., Müller R.H., Müller B.W., Eur. J. Pharm. Biopharm., 49, 143-149 (2000).
18. Gabizon A., Shmeeda H., Barenholz Y., Clin. Pharmacokinet., 42, 419-436 (2003).
19. Müller R. H., Mäder K., Gohla S., Eur. J. Pharm. Biopharm., 50, 161-177 (2000).
20. Wong H. L., Bendayan R., Rauth A. M., Li Y., Wu X. Y., Adv. Drug Deliv. Rev., 59, 491-504 (2007).
21. Hu F. Q., Jiang S. P., Du Y. Z., Yuan H., Ye Y. Q., Zeng S., Int. J. Pharm., 314, 83-89 (2006).
22. Hou D., Xie C., Huang K., Zhu C., Biomaterials, 24, 1781-1785 (2003).
23. Vasir J. K., Reddy M. K., Labhasetwar V. D., Curr. Nanosci., 1, 47-64 (2005).
24. Tranchant T., Besson P., Hoinard C., Delarue J., Antoine J. M., Couet C., Goré J., Biochim. Biophys. Acta, 1345, 151-161 (1997).
25. Yuan H., Miao J., Du Y. Z., You J., Hu F. Q., Zeng S., Int. J. Pharm., 348, 137-145 (2008).